Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.4500
- TODAY'S CHANGE (%)-0.1800 (-4.9587%)
- Bid / Lots3.4300/ 1
- Ask / Lots3.5400/ 3
- Open / Previous Close3.6100 / 3.6300
- Day Range
- 52 Week Range
- Volume930,444
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 4846 | 3.595 |
| 09:34 ET | 1970 | 3.63 |
| 09:36 ET | 912 | 3.66 |
| 09:38 ET | 2700 | 3.64 |
| 09:39 ET | 210 | 3.63 |
| 09:41 ET | 340 | 3.65 |
| 09:43 ET | 2502 | 3.63 |
| 09:45 ET | 200 | 3.64 |
| 09:48 ET | 700 | 3.6401 |
| 09:50 ET | 5200 | 3.65 |
| 09:52 ET | 300 | 3.65 |
| 09:54 ET | 1600 | 3.6603 |
| 09:56 ET | 7771 | 3.69 |
| 09:57 ET | 704 | 3.675 |
| 09:59 ET | 700 | 3.67 |
| 10:01 ET | 1461 | 3.6605 |
| 10:03 ET | 888 | 3.66 |
| 10:06 ET | 2416 | 3.6868 |
| 10:08 ET | 6734 | 3.72 |
| 10:10 ET | 36741 | 3.75 |
| 10:12 ET | 12119 | 3.685 |
| 10:14 ET | 4400 | 3.685 |
| 10:15 ET | 5650 | 3.695 |
| 10:17 ET | 8316 | 3.655 |
| 10:19 ET | 3080 | 3.64 |
| 10:21 ET | 1030 | 3.6399 |
| 10:24 ET | 327 | 3.65 |
| 10:26 ET | 808 | 3.645 |
| 10:28 ET | 5700 | 3.64 |
| 10:30 ET | 18927 | 3.675 |
| 10:32 ET | 700 | 3.675 |
| 10:33 ET | 6295 | 3.655 |
| 10:35 ET | 300 | 3.655 |
| 10:37 ET | 900 | 3.66 |
| 10:39 ET | 14380 | 3.65 |
| 10:44 ET | 200 | 3.66 |
| 10:46 ET | 551 | 3.65 |
| 10:48 ET | 800 | 3.64 |
| 10:50 ET | 1485 | 3.645 |
| 10:51 ET | 1223 | 3.645 |
| 10:53 ET | 2800 | 3.65 |
| 10:55 ET | 2006 | 3.655 |
| 10:57 ET | 2911 | 3.64 |
| 11:00 ET | 400 | 3.65 |
| 11:02 ET | 100 | 3.655 |
| 11:04 ET | 100 | 3.65 |
| 11:06 ET | 1689 | 3.64 |
| 11:08 ET | 875 | 3.63 |
| 11:09 ET | 9649 | 3.6 |
| 11:11 ET | 8758 | 3.595 |
| 11:13 ET | 1985 | 3.585 |
| 11:15 ET | 2500 | 3.58 |
| 11:18 ET | 350 | 3.585 |
| 11:20 ET | 300 | 3.585 |
| 11:22 ET | 500 | 3.585 |
| 11:24 ET | 1300 | 3.5899 |
| 11:26 ET | 600 | 3.585 |
| 11:27 ET | 8061 | 3.585 |
| 11:29 ET | 2027 | 3.585 |
| 11:33 ET | 400 | 3.585 |
| 11:36 ET | 1123 | 3.585 |
| 11:38 ET | 100 | 3.585 |
| 11:40 ET | 345 | 3.5899 |
| 11:42 ET | 100 | 3.585 |
| 11:45 ET | 100 | 3.585 |
| 11:47 ET | 1381 | 3.565 |
| 11:49 ET | 1854 | 3.565 |
| 11:51 ET | 35965 | 3.57 |
| 11:54 ET | 500 | 3.565 |
| 11:56 ET | 400 | 3.565 |
| 11:58 ET | 700 | 3.565 |
| 12:00 ET | 7945 | 3.575 |
| 12:02 ET | 738 | 3.58 |
| 12:03 ET | 100 | 3.575 |
| 12:07 ET | 19543 | 3.605 |
| 12:09 ET | 3750 | 3.605 |
| 12:12 ET | 300 | 3.605 |
| 12:14 ET | 300 | 3.605 |
| 12:16 ET | 7457 | 3.615 |
| 12:18 ET | 200 | 3.615 |
| 12:20 ET | 1800 | 3.615 |
| 12:21 ET | 200 | 3.615 |
| 12:23 ET | 14514 | 3.58 |
| 12:25 ET | 120 | 3.58 |
| 12:27 ET | 304 | 3.585 |
| 12:30 ET | 3245 | 3.585 |
| 12:32 ET | 2155 | 3.59 |
| 12:34 ET | 1957 | 3.575 |
| 12:38 ET | 10000 | 3.575 |
| 12:39 ET | 1765 | 3.565 |
| 12:41 ET | 100 | 3.565 |
| 12:43 ET | 2128 | 3.565 |
| 12:45 ET | 1111 | 3.565 |
| 12:48 ET | 2850 | 3.56 |
| 12:50 ET | 600 | 3.565 |
| 12:52 ET | 468 | 3.57 |
| 12:54 ET | 3609 | 3.545 |
| 12:56 ET | 19053 | 3.555 |
| 12:57 ET | 22539 | 3.535 |
| 12:59 ET | 2600 | 3.535 |
| 01:01 ET | 200 | 3.535 |
| 01:03 ET | 1680 | 3.535 |
| 01:06 ET | 10262 | 3.55 |
| 01:08 ET | 100 | 3.555 |
| 01:10 ET | 481 | 3.555 |
| 01:12 ET | 800 | 3.565 |
| 01:17 ET | 10765 | 3.565 |
| 01:19 ET | 466 | 3.56 |
| 01:21 ET | 1688 | 3.565 |
| 01:24 ET | 100 | 3.57 |
| 01:26 ET | 532 | 3.56 |
| 01:28 ET | 100 | 3.555 |
| 01:30 ET | 100 | 3.55 |
| 01:33 ET | 100 | 3.54 |
| 01:35 ET | 2118 | 3.53 |
| 01:37 ET | 1100 | 3.545 |
| 01:39 ET | 400 | 3.545 |
| 01:42 ET | 100 | 3.545 |
| 01:44 ET | 1040 | 3.54 |
| 01:46 ET | 971 | 3.5401 |
| 01:48 ET | 1182 | 3.54 |
| 01:50 ET | 200 | 3.54 |
| 01:51 ET | 100 | 3.54 |
| 01:53 ET | 100 | 3.54 |
| 01:55 ET | 2100 | 3.555 |
| 01:57 ET | 452 | 3.555 |
| 02:00 ET | 100 | 3.555 |
| 02:02 ET | 100 | 3.555 |
| 02:04 ET | 674 | 3.555 |
| 02:08 ET | 100 | 3.555 |
| 02:09 ET | 200 | 3.555 |
| 02:11 ET | 100 | 3.55 |
| 02:13 ET | 2003 | 3.545 |
| 02:15 ET | 2000 | 3.555 |
| 02:20 ET | 1100 | 3.5503 |
| 02:24 ET | 400 | 3.5597 |
| 02:26 ET | 9577 | 3.545 |
| 02:27 ET | 700 | 3.545 |
| 02:29 ET | 800 | 3.545 |
| 02:31 ET | 4924 | 3.56 |
| 02:33 ET | 900 | 3.555 |
| 02:38 ET | 2586 | 3.56 |
| 02:42 ET | 575 | 3.5599 |
| 02:44 ET | 1500 | 3.555 |
| 02:45 ET | 200 | 3.56 |
| 02:47 ET | 700 | 3.5599 |
| 02:49 ET | 200 | 3.555 |
| 02:51 ET | 200 | 3.56 |
| 02:54 ET | 3008 | 3.54 |
| 02:56 ET | 400 | 3.54 |
| 02:58 ET | 827 | 3.545 |
| 03:00 ET | 3169 | 3.545 |
| 03:02 ET | 400 | 3.54 |
| 03:03 ET | 300 | 3.545 |
| 03:05 ET | 3218 | 3.51 |
| 03:07 ET | 3740 | 3.53 |
| 03:09 ET | 900 | 3.532 |
| 03:12 ET | 1927 | 3.515 |
| 03:14 ET | 14702 | 3.515 |
| 03:16 ET | 2100 | 3.515 |
| 03:18 ET | 3700 | 3.515 |
| 03:20 ET | 2499 | 3.525 |
| 03:21 ET | 100 | 3.525 |
| 03:23 ET | 4100 | 3.5205 |
| 03:25 ET | 15866 | 3.4908 |
| 03:27 ET | 398 | 3.495 |
| 03:30 ET | 13381 | 3.485 |
| 03:32 ET | 15848 | 3.495 |
| 03:34 ET | 1600 | 3.497 |
| 03:36 ET | 27732 | 3.465 |
| 03:38 ET | 1452 | 3.465 |
| 03:39 ET | 13215 | 3.465 |
| 03:41 ET | 2250 | 3.465 |
| 03:43 ET | 33645 | 3.455 |
| 03:45 ET | 10578 | 3.45 |
| 03:48 ET | 4756 | 3.455 |
| 03:50 ET | 3858 | 3.46 |
| 03:52 ET | 13296 | 3.445 |
| 03:54 ET | 18081 | 3.455 |
| 03:56 ET | 5718 | 3.45 |
| 03:57 ET | 5818 | 3.45 |
| 03:59 ET | 18271 | 3.45 |
Jun 20, 2024
DJ Mereo BioPharma Group Is Maintained at Outperform by Leerink Partners, from 8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 14, 2024
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow JonesPress Release: Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 13, 2024
DJ Mereo BioPharma Group Initiated at Outperform by Baird, from 5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 554.7M | -11.0x | --- |
Immunome Inc | 731.6M | -2.1x | --- |
Stoke Therapeutics Inc | 722.9M | -5.3x | --- |
AnaptysBio Inc | 672.3M | -3.9x | --- |
SS Innovations International Inc | 725.6M | -31.0x | --- |
Praxis Precision Medicines Inc | 704.7M | -2.5x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Director
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $554.7M |
|---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 152.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-0.31 |
Book Value | $0.44 |
P/E Ratio | -11.0x |
Price/Sales (TTM) | 55.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
